List of All Articles with Tag 'novo'

(Reuters) -The European Medicines Agency (EMA) is probing Novo Nordisk's diabetes drug Ozempic and weight-loss treatment Saxenda after Iceland's health

Novo Nordisk A/S’s weight-loss medications are under investigation by the European Union’s drugs regulator after a small number

Novo Nordisk A/S sued US pharmacies making and selling versions of semaglutide, the active ingredient in Wegovy, the

An overview of the media in Serbia, including links to broadcasters and newspapers.

Two years and more than a million prescriptions after Wegovy first went on sale, there’s one taboo question

Problems at a Catalent Inc. production facility led US regulators to deny a key drug application from Regeneron

An overview of the media in Belarus, including links to broadcasters and newspapers.

Obesity shots like Wegovy are already a cultural phenomenon. Now it’s looking like pill forms of the drugs

An experimental weight-loss shot from Eli Lilly & Co. yielded the strongest results of any of its treatments

Pfizer Inc. is halting early development of a weight-loss drug on safety concerns, raising investor anxiety about another

By Deena Beasley SAN DIEGO Drugmaker Novo Nordisk on Sunday said a late-stage trial found that a high-dose

Eli Lilly & Co.’s experimental weight-loss pill helped patients shed pounds quickly in a mid-stage trial, setting the